MeSH term
Frequency | Condition_Probility | Humans | 47 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Base Sequence | 4 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Keratin/metabolism | 2 | 1.0 |
Molecular Sequence Data | 7 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 33 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Aged | 9 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Chemotactic Factors/*biosynthesis | 3 | 20.0 |
Disease-Free Survival | 2 | 0.0 |
Immunohistochemistry | 10 | 0.0 |
Middle Aged | 9 | 0.0 |
Prognosis | 3 | 0.0 |
S100 Proteins/*biosynthesis | 4 | 36.0 |
Chemotactic Factors/*biosynthesis/genetics | 3 | 50.0 |
S100 Proteins/*biosynthesis/genetics | 3 | 33.0 |
Animals | 10 | 0.0 |
English Abstract | 2 | 0.0 |
Mice | 4 | 0.0 |
Mice, Nude | 2 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Carcinoma, Non-Small-Cell Lung/genetics/*metabolism/pathology | 2 | 22.0 |
Cell Line, Transformed | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 7 | 0.0 |
Lung Neoplasms/genetics/*metabolism/pathology | 2 | 7.0 |
Neoplasm Staging | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 6 | 0.0 |
Rats | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
*Cell Cycle Proteins | 5 | 0.0 |
Protein Conformation | 2 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Zinc/*chemistry | 2 | 18.0 |
S100 Proteins/*metabolism | 5 | 9.0 |
Neoplasm Metastasis | 2 | 0.0 |
Predictive Value of Tests | 3 | 0.0 |
Female | 10 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Up-Regulation | 2 | 0.0 |
Adult | 7 | 0.0 |
Comparative Study | 2 | 0.0 |
*Gene Expression Profiling | 4 | 0.0 |
Down-Regulation | 2 | 0.0 |
Kinetics | 3 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Chemotactic Factors/*genetics | 3 | 21.0 |
Child | 2 | 0.0 |
Male | 9 | 0.0 |
S100 Proteins/*genetics | 4 | 20.0 |
Cell Line | 8 | 0.0 |
Antibody Specificity | 3 | 0.0 |
Hydrogen Peroxide/pharmacology | 2 | 0.0 |
Molecular Weight | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Circular Dichroism | 2 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Calcium/*metabolism | 5 | 0.0 |
Cattle | 3 | 0.0 |
Rabbits | 2 | 0.0 |
Calcium-Binding Proteins/*genetics | 2 | 2.0 |
Calcium-Binding Proteins/*analysis | 3 | 23.0 |
S100 Proteins/*analysis | 3 | 6.0 |
Thapsigargin/pharmacology | 2 | 1.0 |
S100 Proteins/genetics/*metabolism | 4 | 22.0 |
Calcium-Binding Proteins/*metabolism | 2 | 2.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Chemotactic Factors/genetics/*metabolism | 2 | 50.0 |
Skin Neoplasms/*metabolism/pathology | 2 | 3.0 |
Sweat Gland Neoplasms/*metabolism/pathology | 2 | 100.0 |
Multigene Family | 2 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Chemotactic Factors/*metabolism | 2 | 25.0 |
Tumor Markers, Biological/metabolism | 2 | 0.0 |
Lung Neoplasms/*genetics | 2 | 0.0 |
Chemotactic Factors/genetics/metabolism | 2 | 40.0 |
S100 Proteins/genetics/metabolism | 2 | 33.0 |
